Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

CPSC

This article was originally published in The Tan Sheet

Executive Summary

Commissioner Mary Sheila Gall's confirmation to chair consumer product safety agency delayed due to postponement of June 6 Senate Commerce Committee hearing. Sen. James Jeffords' (I-Vt.) defection from GOP continues to disrupt committee actions as panels are realigned. Trade groups, who view Gall as more industry-friendly, have expressed concern about delay (1"The Tan Sheet" May 14, In Brief). Gall, a holdover from George H. W. Bush's administration, is seen as less apt to aggressively publicize unsafe products. She recently voted to proceed with rulemaking on mandatory Rx-to-OTC switch child-resistant packaging regs, although action on rule is expected to move slowly, according to CHPA

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS092615

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel